Literature DB >> 8405847

Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets.

P J Pasricha1, W J Ravich, A N Kalloo.   

Abstract

BACKGROUND: The toxin of Clostridium botulinum (BoTx) inhibits the release of acetylcholine from nerve terminals and causes paralysis of skeletal muscle. The present study examined the hypothesis that BoTx may have a similar effect on gastrointestinal smooth muscle.
METHODS: Baseline lower esophageal sphincter (LES) pressures were obtained in five piglets, and normal saline was injected endoscopically into the LES. One week later, LES pressure was measured again, followed by injection of BoTx into the LES. After another week, LES pressure was measured again.
RESULTS: Compared with a baseline LES pressure of 8.2 +/- 1.5 mm Hg, LES pressure decreased to 3.2 +/- 1.0 mm Hg after BoTx injection, a reduction of about 60% (P < 0.01). By contrast, LES pressure did not change significantly after normal saline injection. The animals showed no evidence of toxicity. Data from other experiments showed that after injection with toxin, the LES responds normally to bethanechol and pentagastrin but displays a paradoxical response to edrophonium and cholecystokinin.
CONCLUSIONS: BoTx is a potent inhibitor of resting LES tone. Its relatively specific anticholinergic effect may help clarify the role of cholinergic and noncholinergic pathways in the regulation of gastrointestinal sphincters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405847     DOI: 10.1016/0016-5085(93)90947-b

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  Receptors of the enteric nervous system: potential targets for drug therapy.

Authors:  J Tack
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Architecture and function of the gastroesophageal barrier in the piglet.

Authors:  Y Vicente; C Da Rocha; J Yu; G Hernandez-Peredo; L Martinez; B Pérez-Mies; J A Tovar
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

3.  Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin.

Authors:  C Cuillière; P Ducrotté; F Zerbib; E H Metman; D de Looze; F Guillemot; H Hudziak; H Lamouliatte; J C Grimaud; A Ropert; M Dapoigny; R Bost; M Lémann; M A Bigard; P Denis; J L Auget; J P Galmiche; S Bruley des Varannes
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 4.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

5.  Laparoscopic partial myectomy: an experimental reflux model.

Authors:  T P Hüttl; T K Hüttl; R A Lang; G Meyer; M W Wichmann
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

6.  Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.

Authors:  M F Vaezi; J E Richter; C M Wilcox; P L Schroeder; S Birgisson; R L Slaughter; R E Koehler; M E Baker
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

7.  Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia.

Authors:  E Y Eaker; J M Gordon; S B Vogel
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 8.  Endoscopic botox injections in therapy of refractory gastroparesis.

Authors:  Andrew Ukleja; Kanwarpreet Tandon; Kinchit Shah; Alicia Alvarez
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

9.  Differential response of pig masseter to botulinum neurotoxin serotypes a and b.

Authors:  Zi-Jun Liu; Katherine L Rafferty; Wenmin Ye; Susan W Herring
Journal:  Muscle Nerve       Date:  2015-05-29       Impact factor: 3.217

10.  Comparison between botulinum injection and removable covered self-expanding metal stents for the treatment of achalasia.

Authors:  Xiao Bo Cai; Yan Miao Dai; Xin Jian Wan; Yue Zeng; Feng Liu; Dong Wang; Hui Zhou
Journal:  Dig Dis Sci       Date:  2013-02-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.